JAK2 resulted constitutively activated in the rare t(9;12)(p24;p13) encoding ETV6-JAK2 fusion oncoprotein, while JAK1 is widely mutated in adult T-ALL (18 %) and less in children (3 %), and associates with a poor response to therapy [72]. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.